Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation

Detalhes bibliográficos
Autor(a) principal: Ciciliato, Murilo Piologo [UNESP]
Data de Publicação: 2022
Outros Autores: Souza, Matheus Chiaradia de [UNESP], Tarran, Carolina Mendes [UNESP], Castilho, Ana Laura Tironi de[UNESP], Vieira, Ana Júlia [UNESP], Rozza, Ariane Leite [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.3390/pharmaceutics14040755
http://hdl.handle.net/11449/239889
Resumo: Gastric ulcer is one of the most frequent gastrointestinal disorders, and there is an increasing search for natural products that can heal ulcers and avoid their recurrence. We aimed to evaluate the gastroprotective activity of vanillin, including the investigation of anti-inflammatory activity and the modulation of gene expression. Wistar rats were orally treated with vehicle, carbenoxolone, or vanillin (25, 50, or 100 mg/kg) and orally received absolute ethanol to develop gastric ulcers. We analyzed the ulcer area, conducted histological analysis, and measured the levels of the inflammatory cytokines TNF-α, IL-6, IL-1β, and IFN-γ, and anti-inflammatory cytokine IL-10 by ELISA. We analyzed mRNA expression for NF-κB, TNF-α, and Il-10. We measured NOx levels using the Griess reaction. Our results showed similar gastroprotection for the three doses. Vanillin increased mucus production and preserved gastric mucosa integrity. The gastroprotective effect was linked to anti-inflammatory activity as a result of decreasing the levels of TNF-α, IL-6, IL-1β, and IFN-γ and increasing IL-10 levels. Vanillin downregulated the mRNA expression of NF-κB and TNF-α, upregulated the mRNA expression of Il-10, and increased NOx levels in the stomach. The gastroprotective activity of vanillin is related to the maintenance of gastric mucus and the local inflammatory response modulation.
id UNSP_2f3f4ddb828cfcef290b0197fa9bf6ec
oai_identifier_str oai:repositorio.unesp.br:11449/239889
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer FormationELISAIFN-γIL-1βinflammationNF-κBNOqPCRstomachTNF-αvanillinGastric ulcer is one of the most frequent gastrointestinal disorders, and there is an increasing search for natural products that can heal ulcers and avoid their recurrence. We aimed to evaluate the gastroprotective activity of vanillin, including the investigation of anti-inflammatory activity and the modulation of gene expression. Wistar rats were orally treated with vehicle, carbenoxolone, or vanillin (25, 50, or 100 mg/kg) and orally received absolute ethanol to develop gastric ulcers. We analyzed the ulcer area, conducted histological analysis, and measured the levels of the inflammatory cytokines TNF-α, IL-6, IL-1β, and IFN-γ, and anti-inflammatory cytokine IL-10 by ELISA. We analyzed mRNA expression for NF-κB, TNF-α, and Il-10. We measured NOx levels using the Griess reaction. Our results showed similar gastroprotection for the three doses. Vanillin increased mucus production and preserved gastric mucosa integrity. The gastroprotective effect was linked to anti-inflammatory activity as a result of decreasing the levels of TNF-α, IL-6, IL-1β, and IFN-γ and increasing IL-10 levels. Vanillin downregulated the mRNA expression of NF-κB and TNF-α, upregulated the mRNA expression of Il-10, and increased NOx levels in the stomach. The gastroprotective activity of vanillin is related to the maintenance of gastric mucus and the local inflammatory response modulation.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Structural and Functional Biology Institute of Biosciences São Paulo State University (UNESP), Dr Antonio Celso W Zanin Street 250Department of Structural and Functional Biology Institute of Biosciences São Paulo State University (UNESP), Dr Antonio Celso W Zanin Street 250FAPESP: 2018/11484-2Universidade Estadual Paulista (UNESP)Ciciliato, Murilo Piologo [UNESP]Souza, Matheus Chiaradia de [UNESP]Tarran, Carolina Mendes [UNESP]Castilho, Ana Laura Tironi de[UNESP]Vieira, Ana Júlia [UNESP]Rozza, Ariane Leite [UNESP]2023-03-01T19:51:59Z2023-03-01T19:51:59Z2022-04-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.3390/pharmaceutics14040755Pharmaceutics, v. 14, n. 4, 2022.1999-4923http://hdl.handle.net/11449/23988910.3390/pharmaceutics140407552-s2.0-85128260758Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengPharmaceuticsinfo:eu-repo/semantics/openAccess2023-03-01T19:51:59Zoai:repositorio.unesp.br:11449/239889Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T13:41:58.539177Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation
title Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation
spellingShingle Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation
Ciciliato, Murilo Piologo [UNESP]
ELISA
IFN-γ
IL-1β
inflammation
NF-κB
NO
qPCR
stomach
TNF-α
vanillin
title_short Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation
title_full Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation
title_fullStr Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation
title_full_unstemmed Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation
title_sort Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation
author Ciciliato, Murilo Piologo [UNESP]
author_facet Ciciliato, Murilo Piologo [UNESP]
Souza, Matheus Chiaradia de [UNESP]
Tarran, Carolina Mendes [UNESP]
Castilho, Ana Laura Tironi de[UNESP]
Vieira, Ana Júlia [UNESP]
Rozza, Ariane Leite [UNESP]
author_role author
author2 Souza, Matheus Chiaradia de [UNESP]
Tarran, Carolina Mendes [UNESP]
Castilho, Ana Laura Tironi de[UNESP]
Vieira, Ana Júlia [UNESP]
Rozza, Ariane Leite [UNESP]
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
dc.contributor.author.fl_str_mv Ciciliato, Murilo Piologo [UNESP]
Souza, Matheus Chiaradia de [UNESP]
Tarran, Carolina Mendes [UNESP]
Castilho, Ana Laura Tironi de[UNESP]
Vieira, Ana Júlia [UNESP]
Rozza, Ariane Leite [UNESP]
dc.subject.por.fl_str_mv ELISA
IFN-γ
IL-1β
inflammation
NF-κB
NO
qPCR
stomach
TNF-α
vanillin
topic ELISA
IFN-γ
IL-1β
inflammation
NF-κB
NO
qPCR
stomach
TNF-α
vanillin
description Gastric ulcer is one of the most frequent gastrointestinal disorders, and there is an increasing search for natural products that can heal ulcers and avoid their recurrence. We aimed to evaluate the gastroprotective activity of vanillin, including the investigation of anti-inflammatory activity and the modulation of gene expression. Wistar rats were orally treated with vehicle, carbenoxolone, or vanillin (25, 50, or 100 mg/kg) and orally received absolute ethanol to develop gastric ulcers. We analyzed the ulcer area, conducted histological analysis, and measured the levels of the inflammatory cytokines TNF-α, IL-6, IL-1β, and IFN-γ, and anti-inflammatory cytokine IL-10 by ELISA. We analyzed mRNA expression for NF-κB, TNF-α, and Il-10. We measured NOx levels using the Griess reaction. Our results showed similar gastroprotection for the three doses. Vanillin increased mucus production and preserved gastric mucosa integrity. The gastroprotective effect was linked to anti-inflammatory activity as a result of decreasing the levels of TNF-α, IL-6, IL-1β, and IFN-γ and increasing IL-10 levels. Vanillin downregulated the mRNA expression of NF-κB and TNF-α, upregulated the mRNA expression of Il-10, and increased NOx levels in the stomach. The gastroprotective activity of vanillin is related to the maintenance of gastric mucus and the local inflammatory response modulation.
publishDate 2022
dc.date.none.fl_str_mv 2022-04-01
2023-03-01T19:51:59Z
2023-03-01T19:51:59Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3390/pharmaceutics14040755
Pharmaceutics, v. 14, n. 4, 2022.
1999-4923
http://hdl.handle.net/11449/239889
10.3390/pharmaceutics14040755
2-s2.0-85128260758
url http://dx.doi.org/10.3390/pharmaceutics14040755
http://hdl.handle.net/11449/239889
identifier_str_mv Pharmaceutics, v. 14, n. 4, 2022.
1999-4923
10.3390/pharmaceutics14040755
2-s2.0-85128260758
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Pharmaceutics
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128267696209920